Flavonoids as promoters of the (pseudo-)halogenating activity of lactoperoxidase and myeloperoxidase.
暂无分享,去创建一个
[1] J. Flemmig,et al. Lactoperoxidase as a potential drug target , 2016, Expert opinion on therapeutic targets.
[2] C. Obinger,et al. Enhancing hypothiocyanite production by lactoperoxidase – mechanism and chemical properties of promotors , 2015, Biochemistry and biophysics reports.
[3] J. Flemmig,et al. Leonurus cardiaca L. herb extracts and their constituents promote lactoperoxidase activity , 2015 .
[4] S. Hofbauer,et al. Independent evolution of four heme peroxidase superfamilies , 2015, Archives of biochemistry and biophysics.
[5] J. Chandler,et al. Biochemical mechanisms and therapeutic potential of pseudohalide thiocyanate in human health , 2015, Free radical research.
[6] M. Jijakli,et al. Mode of Action of Lactoperoxidase as Related to Its Antimicrobial Activity: A Review , 2014, Enzyme research.
[7] A. Kettle,et al. Uric Acid and Thiocyanate as Competing Substrates of Lactoperoxidase* , 2014, The Journal of Biological Chemistry.
[8] J. Flemmig,et al. Components of a standardised olive leaf dry extract (Ph. Eur.) promote hypothiocyanite production by lactoperoxidase. , 2014, Archives of biochemistry and biophysics.
[9] G. O. Bonilla-Rodriguez,et al. Immobilization of a Plant Lipase from Pachira aquatica in Alginate and Alginate/PVA Beads , 2014, Enzyme research.
[10] G. Pairaudeau,et al. Potent Reversible Inhibition of Myeloperoxidase by Aromatic Hydroxamates* , 2013, The Journal of Biological Chemistry.
[11] Sujata Sharma,et al. Lactoperoxidase: structural insights into the function,ligand binding and inhibition. , 2013, International journal of biochemistry and molecular biology.
[12] J. Chandler,et al. Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties. , 2012, Biochemical pharmacology.
[13] T. R. Middya,et al. A QSAR study of radical scavenging antioxidant activity of a series of flavonoids using DFT based quantum chemical descriptors – the importance of group frontier electron density , 2012, Journal of Molecular Modeling.
[14] G. Stoner,et al. Effects of Human Oral Mucosal Tissue, Saliva, and Oral Microflora on Intraoral Metabolism and Bioactivation of Black Raspberry Anthocyanins , 2011, Cancer Prevention Research.
[15] M. Davies. Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention , 2010, Journal of clinical biochemistry and nutrition.
[16] I. Gülçin,et al. Interactions of melatonin and serotonin with lactoperoxidase enzyme , 2010, Journal of enzyme inhibition and medicinal chemistry.
[17] J. Arnhold,et al. Human myeloperoxidase in innate and acquired immunity. , 2010, Archives of biochemistry and biophysics.
[18] M. Serafini,et al. Flavonoids as anti-inflammatory agents , 2010, Proceedings of the Nutrition Society.
[19] Sujata Sharma,et al. First structural evidence for the mode of diffusion of aromatic ligands and ligand-induced closure of the hydrophobic channel in heme peroxidases , 2010, JBIC Journal of Biological Inorganic Chemistry.
[20] C. Obinger,et al. (-)-Epicatechin enhances the chlorinating activity of human myeloperoxidase. , 2010, Archives of biochemistry and biophysics.
[21] Szilvia Szép,et al. The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases , 2009, Proceedings of the National Academy of Sciences.
[22] Sujata Sharma,et al. Inhibition of lactoperoxidase by its own catalytic product: crystal structure of the hypothiocyanate-inhibited bovine lactoperoxidase at 2.3-A resolution. , 2009, Biophysical journal.
[23] C. Obinger,et al. Kinetic evidence for rapid oxidation of (-)-epicatechin by human myeloperoxidase. , 2008, Biochemical and biophysical research communications.
[24] Ł. Minarowski,et al. Thiocyanate concentration in saliva of cystic fibrosis patients. , 2008, Folia histochemica et cytobiologica.
[25] D. Ferreira,et al. Theoretical calculation of electronic circular dichroism of the rotationally restricted 3,8''-biflavonoid morelloflavone. , 2007, The Journal of organic chemistry.
[26] Sujata Sharma,et al. Crystal structure of lactoperoxidase at 2.4 A resolution. , 2007, Journal of molecular biology.
[27] M. Tao,et al. Circadian rhythm of salivary serotonin in patients with major depressive disorder. , 2007, Neuro endocrinology letters.
[28] D. Glossman-Mitnik,et al. Theoretical study of the molecular properties and chemical reactivity of (+)-catechin and (−)-epicatechin related to their antioxidant ability , 2006 .
[29] C. Obinger,et al. Active site structure and catalytic mechanisms of human peroxidases. , 2006, Archives of biochemistry and biophysics.
[30] C. Obinger,et al. Reaction of ferrous lactoperoxidase with hydrogen peroxide and dioxygen: an anaerobic stopped-flow study. , 2005, Archives of biochemistry and biophysics.
[31] M. Ashby,et al. Redox buffering of hypochlorous acid by thiocyanate in physiologic fluids. , 2004, Journal of the American Chemical Society.
[32] C. Obinger,et al. Direct conversion of ferrous myeloperoxidase to compound II by hydrogen peroxide: an anaerobic stopped-flow study. , 2003, Biochemical and biophysical research communications.
[33] C. Obinger,et al. Redox properties of the couples compound I/compound II and compound II/native enzyme of human myeloperoxidase. , 2003, Biochemical and biophysical research communications.
[34] E. Laurenti,et al. Organic and inorganic substrates as probes for comparing native bovine lactoperoxidase and recombinant human myeloperoxidase. , 2003, Journal of inorganic biochemistry.
[35] C. Obinger,et al. Reaction of lactoperoxidase compound I with halides and thiocyanate. , 2002, Biochemistry.
[36] C. Obinger,et al. Redox intermediates of plant and mammalian peroxidases: a comparative transient-kinetic study of their reactivity toward indole derivatives. , 2002, Archives of biochemistry and biophysics.
[37] P. O'Brien,et al. Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation. , 2001, Free radical biology & medicine.
[38] C. Obinger,et al. Two‐electron reduction and one‐electron oxidation of organic hydroperoxides by human myeloperoxidase , 2000, FEBS letters.
[39] A. V. van Hooijdonk,et al. Lactoperoxidase: physico-chemical properties, occurrence, mechanism of action and applications , 2000, British Journal of Nutrition.
[40] R. Fenna,et al. X-ray Crystal Structure and Characterization of Halide-binding Sites of Human Myeloperoxidase at 1.8 Å Resolution* , 2000, The Journal of Biological Chemistry.
[41] C. Obinger,et al. Transient and Steady-state Kinetics of the Oxidation of Substituted Benzoic Acid Hydrazides by Myeloperoxidase* , 1999, The Journal of Biological Chemistry.
[42] C. Obinger,et al. Reaction of myeloperoxidase compound I with chloride, bromide, iodide, and thiocyanate. , 1998, Biochemistry.
[43] G. Kerkhof,et al. Correlation between concentrations of melatonin in saliva and serum in patients with delayed sleep phase syndrome. , 1998, Therapeutic drug monitoring.
[44] A. Kettle,et al. Thiocyanate and chloride as competing substrates for myeloperoxidase. , 1997, The Biochemical journal.
[45] D. Dawson,et al. Salivary Melatonin as a Circadian Phase Marker: Validation and Comparison to Plasma Melatonin , 1997, Journal of Biological Rhythms.
[46] B. W. Clare. Charge transfer complexes and frontier orbital energies in QSAR: a congeneric series of electron acceptors , 1995 .
[47] C. Rice-Evans,et al. Antioxidant activity of saliva and periodontal disease. , 1994, Free radical research.
[48] F. Lagerlöf. Caries-Protective Factors in Saliva , 1994, Advances in dental research.
[49] M. Quirynen,et al. Effect of a lactoperoxidase containing toothpaste in radiation-induced xerostomia. , 1994, International dental journal.
[50] H. Dunford,et al. Spectral and kinetic studies on the formation of myeloperoxidase compounds I and II: roles of hydrogen peroxide and superoxide. , 1994, Biochemistry.
[51] V. H. Lee,et al. Drug metabolism in the oral cavity , 1993 .
[52] F. Rahemtulla,et al. Quantitative, standardized assays for determining the concentrations of bovine lactoperoxidase, human salivary peroxidase, and human myeloperoxidase. , 1990, Analytical biochemistry.
[53] R. Arnold,et al. Inhibition of dental plaque acid production by the salivary lactoperoxidase antimicrobial system , 1981, Infection and immunity.
[54] M. Jefferson,et al. Hypothiocyanite Ion: Detection of the Antimicrobial Agent in Human Saliva , 1980, Journal of dental research.
[55] J. Flemmig,et al. (-)-Epicatechin regenerates the chlorinating activity of myeloperoxidase in vitro and in neutrophil granulocytes. , 2014, Journal of inorganic biochemistry.
[56] Liangliang Xie,et al. Characterization and density functional theory study of the antioxidant activity of quercetin and its sugar-containing analogues , 2013, European Food Research and Technology.
[57] A. Kettle,et al. Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione. , 2009, The Biochemical journal.
[58] T. Walle,et al. Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. , 2005, The Journal of nutrition.
[59] F. Tomás-Barberán,et al. Flavonoids in Food and Their Health Benefits , 2004, Plant foods for human nutrition.
[60] C. Rice-Evans,et al. Structure-antioxidant activity relationships of flavonoids and phenolic acids. , 1996, Free radical biology & medicine.
[61] J. Robinson,et al. Drug delivery via the mucous membranes of the oral cavity. , 1992, Journal of pharmaceutical sciences.
[62] H. Hoogendoorn,et al. Lactoperoxidase in the prevention of plaque accumulation, gingivitis and dental caries. I. Effect on oral streptococci and lactobacilli. , 1973, Odontologisk revy.